ProKidney Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for ProKidney Corp. (PROK) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-163.34-35.47-108.03-55.15-26.75
Depreciation & Amortization5.433.853.041.980.96
Stock Based Compensation29.3730.8574.470.700.73
Change in Working Capital3.9616.67-6.462.16-0.13
Change in Accounts Receivable-1.070.000.000.000.00
Change in Accounts Payable10.9811.640.497.870.68
Change in Other Working Capital-0.163.27-7.23-5.70-0.81
Other Operating Activities-0.16-99.98-40.100.000.00
Net Cash from Operating Activities-126.35-90.07-77.09-50.30-25.18
Investing Activities
Capital Expenditures-29.51-34.20-1.85-5.19-5.46
Purchases of Investments-324.02-295.790.000.000.00
Sales/Maturities of Investments373.95175.820.000.000.00
Other Investing Activities0.000.000.110.000.00
Net Cash from Investing Activities20.41-329.98-1.74-5.19-5.46
Financing Activities
Debt Repayment-0.05-0.05-35.03-0.03-0.01
Common Stock Issued144.320.006.0571.5020.00
Common Stock Repurchased0.00-9.500.000.000.00
Other Financing Activities0.140.00542.5071.500.00
Net Cash from Financing Activities144.41-9.55548.5271.4719.99
Summary
Net Change in Cash38.47-429.60469.6915.98-10.65
Cash at Beginning of Period60.65490.2520.564.580.00
Cash at End of Period99.1260.65490.2520.560.00
Free Cash Flow-155.86-124.27-78.94-55.49-30.64
Supplemental Disclosures
Income Taxes Paid0.072.861.950.070.00